Neuropharmacokinetic characterization of lamotrigine after its acute administration to rats

被引:7
作者
Castel-Branco, MM
Falcao, AC [1 ]
Figueiredo, IV
Caramona, MM
Lanao, JM
机构
[1] Univ Coimbra, Fac Pharm, Pharmacol Lab, P-3000925 Coimbra, Portugal
[2] Univ Salamanca, Fac Pharm, Dept Pharm & Pharmaceut Technol, E-37008 Salamanca, Spain
来源
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 2005年 / 27卷 / 08期
基金
英国惠康基金;
关键词
brain; lamotrigine; pharmacokinetics; plasma; rats;
D O I
10.1358/mf.2005.27.8.928299
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study is to characterize the neuropharmacokinetics of lamotrigine following a single intraperitoneal dose. Adult male Wistar rats were given lamotrigine dose a 5, 10, or 20 mg/kg. Blood and brain samples were obtained at predetermined times over 120 h and analyzed by HPLC. The overall characteristics of plasma curves were determined by noncompartmental analysis with WINNONLIN (R). The kinetic characterization of lamotrigine distribution between plasma and brain was performed by indirect numerical deconvolution with MULTI(FILT)((R)). A linear disposition kinetics was observed within 5-20 mg/kg. The lamotrigine concentrations in brain homogenate were approx. twofold higher than in plasma. The following pharmacokinetic parameters were obtained for lamotrigine 5, 10, and 20 mg/kg, respectively: clearance of distribution from plasma to brain normalized with the volume of the brain, CLIV(h(-1)) = 4.64, 2.47, 2.40; brain-to-plasma partition coefficient, P = 0.40. 0.37, 0.34;.first-order transfer rate constant from the brain to the plasma, K(h(-1)) = 11.68, 6.68, 5.96; single-pass mean transit time in the brain, MTT(h) = 0.086, 0.150, 0.168. These results indicate that lamotrigine plasma levels may be good indicators of lamotrigine levels in the brain and that higher response intensities could be expected with hixgher doses of lamotrigine, since efficacious concentrations are maintained for a longer period.
引用
收藏
页码:539 / 545
页数:7
相关论文
共 31 条
[1]  
ADUSUMALLI VE, 1993, DRUG METAB DISPOS, V21, P1079
[2]   The influence of dosage, age, and comedication on steady state plasma lamotrigine concentrations in epileptic children: A prospective study with preliminary assessment of correlations with clinical response [J].
Bartoli, A ;
Guerrini, R ;
Belmonte, A ;
Alessandri, MG ;
Gatti, G ;
Perucca, E .
THERAPEUTIC DRUG MONITORING, 1997, 19 (03) :252-260
[3]   Lamotrigine kidney distribution in male rats following a single intraperitoneal dose [J].
Castel-Branco, MM ;
Falcao, AC ;
Figueiredo, IV ;
Macedo, TRA ;
Caramona, MM .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 (01) :51-55
[4]   Influence of administration vehicles and drug formulations on the pharmacokinetic profile of lamotrigine in rats [J].
Castel-Branco, MM ;
Figueiredo, IV ;
Falcao, AC ;
Macedo, TRA ;
Caramona, MM .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2002, 16 (05) :331-336
[5]   Lamotrigine analysis in blood and brain by high-performance liquid chromatography [J].
Castel-Branco, MM ;
Almeida, AM ;
Falcao, AC ;
Macedo, TA ;
Caramona, MM ;
Lopez, FG .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2001, 755 (1-2) :119-127
[6]   Review of lamotrigine and its clinical applications in epilepsy [J].
Choi, H ;
Morrell, MJ .
EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (02) :243-251
[7]   LINEAR-SYSTEMS ANALYSIS IN PHARMACOKINETICS [J].
CUTLER, DJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1978, 6 (03) :265-282
[8]   Study on brain interstitial fluid distribution and blood-brain barrier transport of baclofen in rats by microdialysis [J].
Deguchi, Y ;
Inabe, K ;
Tomiyasu, K ;
Nozawa, K ;
Yamada, S ;
Kimura, R .
PHARMACEUTICAL RESEARCH, 1995, 12 (12) :1838-1844
[9]   Long-term tolerability of lamotrigine: data from a 6-year continuation study [J].
Faught, E ;
Matsuo, FU ;
Schachter, S ;
Messenheimer, J ;
Womble, GP .
EPILEPSY & BEHAVIOR, 2004, 5 (01) :31-36
[10]  
Fröscher W, 2002, EPILEPTIC DISORD, V4, P49